FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000425963> ?p ?o ?g. }

• W2000425963 endingPage "1012" @default.
• W2000425963 startingPage "1006" @default.
• W2000425963 abstract "The effects of YM337, the Fab fragment of a humanized anti-glycoprotein IIb/IIIa (GPIIb/IIIa) monoclonal antibody C4G1, on in vitro platelet function and binding properties were compared with those of abciximab, the Fab fragment of the human/murine chimeric anti-GPIIb/IIIa monoclonal antibody 7E3. Both agents completely inhibited platelet aggregation caused by all agonists tested except ristocetin. Further, both inhibited human platelet adhesion to von Willebrand factor, fibrinogen, fibronectin and subendothelial matrix with similar potency. Fibrinogen binding to washed platelets was dose-dependently inhibited by both agents. In binding assay using 125I-YM337 and 125I-abciximab, Kd values determined with platelet-rich plasma were 6.74 +/- 0.56 nM for YM337 and 6.65 +/- 1.45 nM for abciximab, and the number of binding sites were 42,700 +/- 3,000 for YM337 and 76,000 +/- 5,400 for abciximab. GPIIb/IIIa was precipitated from the solubilized fraction of platelets by both agents. In contrast, integrin alphavbeta3 was precipitated from the solubilized fraction of human umbilical vein endothelial cells by abciximab but not by YM337. Fibrinogen binding to purified GPIIb/IIIa was dose-dependently inhibited by both agents. In contrast, vitronectin binding to purified integrin alphavbeta3 was dose-dependently inhibited by abciximab but not by YM337, supporting the idea that abciximab reacts to integrin alphavbeta3. Therefore, YM337 was suggested to bind to a different epitope of GPIIb/IIIa from abciximab. These results suggest that YM337 specifically acts on platelet GPIIb/IIIa receptors and has similar inhibitory properties on platelet aggregation and platelet adhesion to abciximab." @default.
• W2000425963 created "2016-06-24" @default.
• W2000425963 creator A5028109593 @default.
• W2000425963 creator A5036834474 @default.
• W2000425963 creator A5041324376 @default.
• W2000425963 creator A5061406420 @default.
• W2000425963 creator A5062104011 @default.
• W2000425963 creator A5069920641 @default.
• W2000425963 creator A5081636112 @default.
• W2000425963 date "2002-01-01" @default.
• W2000425963 modified "2023-10-14" @default.
• W2000425963 title "Comparative Studies of a Humanized Anti-glycoprotein IIb/IIIa Monoclonal Antibody, YM337, and Abciximab on in Vitro Antiplatelet Effect and Binding Properties." @default.
• W2000425963 cites W1007489501 @default.
• W2000425963 cites W152541204 @default.
• W2000425963 cites W1535173945 @default.
• W2000425963 cites W1562376535 @default.
• W2000425963 cites W1602182436 @default.
• W2000425963 cites W1976353181 @default.
• W2000425963 cites W1976666984 @default.
• W2000425963 cites W2000785671 @default.
• W2000425963 cites W2005436756 @default.
• W2000425963 cites W2006006858 @default.
• W2000425963 cites W2012330153 @default.
• W2000425963 cites W2029231027 @default.
• W2000425963 cites W2052356524 @default.
• W2000425963 cites W2052899600 @default.
• W2000425963 cites W2068153038 @default.
• W2000425963 cites W2090959366 @default.
• W2000425963 cites W2108703365 @default.
• W2000425963 cites W2160034002 @default.
• W2000425963 cites W2170684533 @default.
• W2000425963 cites W2181035007 @default.
• W2000425963 cites W2398780564 @default.
• W2000425963 cites W2402528691 @default.
• W2000425963 cites W2441496056 @default.
• W2000425963 cites W3022148767 @default.
• W2000425963 cites W3116925564 @default.
• W2000425963 cites W4230017930 @default.
• W2000425963 cites W4238269453 @default.
• W2000425963 cites W4245860073 @default.
• W2000425963 doi "https://doi.org/10.1248/bpb.25.1006" @default.
• W2000425963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12186399" @default.
• W2000425963 hasPublicationYear "2002" @default.
• W2000425963 type Work @default.
• W2000425963 sameAs 2000425963 @default.
• W2000425963 citedByCount "9" @default.
• W2000425963 countsByYear W20004259632012 @default.
• W2000425963 countsByYear W20004259632017 @default.
• W2000425963 countsByYear W20004259632019 @default.
• W2000425963 countsByYear W20004259632021 @default.
• W2000425963 crossrefType "journal-article" @default.
• W2000425963 hasAuthorship W2000425963A5028109593 @default.
• W2000425963 hasAuthorship W2000425963A5036834474 @default.
• W2000425963 hasAuthorship W2000425963A5041324376 @default.
• W2000425963 hasAuthorship W2000425963A5061406420 @default.
• W2000425963 hasAuthorship W2000425963A5062104011 @default.
• W2000425963 hasAuthorship W2000425963A5069920641 @default.
• W2000425963 hasAuthorship W2000425963A5081636112 @default.
• W2000425963 hasBestOaLocation W20004259631 @default.
• W2000425963 hasConcept C126322002 @default.
• W2000425963 hasConcept C153911025 @default.
• W2000425963 hasConcept C159654299 @default.
• W2000425963 hasConcept C164144092 @default.
• W2000425963 hasConcept C170493617 @default.
• W2000425963 hasConcept C185592680 @default.
• W2000425963 hasConcept C195687474 @default.
• W2000425963 hasConcept C202751555 @default.
• W2000425963 hasConcept C203014093 @default.
• W2000425963 hasConcept C26828662 @default.
• W2000425963 hasConcept C2777292125 @default.
• W2000425963 hasConcept C2777871224 @default.
• W2000425963 hasConcept C2778863912 @default.
• W2000425963 hasConcept C2779036427 @default.
• W2000425963 hasConcept C3018697912 @default.
• W2000425963 hasConcept C45393284 @default.
• W2000425963 hasConcept C500558357 @default.
• W2000425963 hasConcept C542903549 @default.
• W2000425963 hasConcept C55493867 @default.
• W2000425963 hasConcept C71924100 @default.
• W2000425963 hasConcept C86803240 @default.
• W2000425963 hasConcept C89560881 @default.
• W2000425963 hasConcept C98274493 @default.
• W2000425963 hasConceptScore W2000425963C126322002 @default.
• W2000425963 hasConceptScore W2000425963C153911025 @default.
• W2000425963 hasConceptScore W2000425963C159654299 @default.
• W2000425963 hasConceptScore W2000425963C164144092 @default.
• W2000425963 hasConceptScore W2000425963C170493617 @default.
• W2000425963 hasConceptScore W2000425963C185592680 @default.
• W2000425963 hasConceptScore W2000425963C195687474 @default.
• W2000425963 hasConceptScore W2000425963C202751555 @default.
• W2000425963 hasConceptScore W2000425963C203014093 @default.
• W2000425963 hasConceptScore W2000425963C26828662 @default.
• W2000425963 hasConceptScore W2000425963C2777292125 @default.
• W2000425963 hasConceptScore W2000425963C2777871224 @default.
• W2000425963 hasConceptScore W2000425963C2778863912 @default.
• W2000425963 hasConceptScore W2000425963C2779036427 @default.
• W2000425963 hasConceptScore W2000425963C3018697912 @default.
• W2000425963 hasConceptScore W2000425963C45393284 @default.

• next